Published in J Immunol Methods on July 24, 2012
Antigenic properties of the human immunodeficiency virus envelope glycoprotein gp120 on virions bound to target cells. PLoS Pathog (2015) 1.50
Independent evolution of Fc- and Fab-mediated HIV-1-specific antiviral antibody activity following acute infection. Eur J Immunol (2014) 0.96
Comparative efficiency of HIV-1-infected T cell killing by NK cells, monocytes and neutrophils. PLoS One (2013) 0.95
HIV-specific CD4-induced Antibodies Mediate Broad and Potent Antibody-dependent Cellular Cytotoxicity Activity and Are Commonly Detected in Plasma From HIV-infected humans. EBioMedicine (2015) 0.88
Low antibody-dependent cellular cytotoxicity responses in Zambians prior to HIV-1 intrasubtype C superinfection. Virology (2014) 0.82
CD16 expression on monocytes in healthy individuals but not schistosome-infected patients is positively associated with levels of parasite-specific IgG and IgG1. PLoS Negl Trop Dis (2014) 0.79
Paring Down HIV Env: Design and Crystal Structure of a Stabilized Inner Domain of HIV-1 gp120 Displaying a Major ADCC Target of the A32 Region. Structure (2016) 0.79
Boosting of ALVAC-SIV Vaccine-Primed Macaques with the CD4-SIVgp120 Fusion Protein Elicits Antibodies to V2 Associated with a Decreased Risk of SIVmac251 Acquisition. J Immunol (2016) 0.78
Chronic Effects of Ethanol and/or Darunavir/Ritonavir on U937 Monocytic Cells: Regulation of Cytochrome P450 and Antioxidant Enzymes, Oxidative Stress, and Cytotoxicity. Alcohol Clin Exp Res (2016) 0.78
Antibody-dependent CD56+ T cell responses are functionally impaired in long-term HIV-1 infection. Retrovirology (2016) 0.75
Cell-targeting antibodies in immunity to Ebola. Pathog Dis (2016) 0.75
HIV-1 Env- and Vpu-specific antibody-dependent cellular cytotoxicity responses associated with elite control of HIV. J Virol (2017) 0.75
Early highly active antiretroviral therapy for acute HIV-1 infection preserves immune function of CD8+ and CD4+ T lymphocytes. Proc Natl Acad Sci U S A (2000) 3.66
Neurological manifestations of enterovirus 71 infection in children during an outbreak of hand, foot, and mouth disease in Western Australia. Clin Infect Dis (2000) 3.41
Nucleotide sequence coding for the respiratory NADH dehydrogenase of Escherichia coli. UUG initiation codon. Eur J Biochem (1981) 2.73
Crystal structure of human T cell leukemia virus type 1 gp21 ectodomain crystallized as a maltose-binding protein chimera reveals structural evolution of retroviral transmembrane proteins. Proc Natl Acad Sci U S A (1999) 2.32
Serum IgG subclass concentrations in healthy adults: a study using monoclonal antisera. Clin Exp Immunol (1984) 1.99
Potent antiretroviral therapy of primary human immunodeficiency virus type 1 (HIV-1) infection: partial normalization of T lymphocyte subsets and limited reduction of HIV-1 DNA despite clearance of plasma viremia. J Infect Dis (1999) 1.70
Amplification of the respiratory NADH dehydrogenase of Escherichia coli by gene cloning. Gene (1978) 1.67
Systemic antibody deficiency in patients without serum immunoglobulin deficiency or with selective IgA deficiency. Clin Exp Immunol (1984) 1.48
Patterns of viral dynamics during primary human immunodeficiency virus type 1 infection. The Sydney Primary HIV Infection Study Group. J Infect Dis (1998) 1.41
Polymorphic MHC ancestral haplotypes affect the activity of tumour necrosis factor-alpha. Clin Exp Immunol (1993) 1.39
Chain shortening of palmitic acid in human subjects. Am J Clin Nutr (1988) 1.39
Efficacy of DNA and fowlpox virus priming/boosting vaccines for simian/human immunodeficiency virus. J Virol (2004) 1.39
Hepatitis C virus-associated hepatitis following treatment of HIV-infected patients with HIV protease inhibitors: an immune restoration disease? AIDS (1998) 1.38
Cytotoxic T lymphocyte responses to human immunodeficiency virus: control and escape. Stem Cells (2000) 1.38
Cerebral mass lesions due to cytomegalovirus in patients with AIDS: report of two cases. J Infect (1995) 1.38
Antibody-dependent cellular cytotoxicity of human vascular endothelium in systemic sclerosis. Clin Exp Immunol (1984) 1.37
Transmission of triple-class, drug-resistant HIV-1 in Australia. Intern Med J (2010) 1.37
Human immunodeficiency virus type 1 envelope glycoprotein oligomerization requires the gp41 amphipathic alpha-helical/leucine zipper-like sequence. J Virol (1997) 1.31
A method of removing starch powder from surgeons' gloves. Ann R Coll Surg Engl (1975) 1.30
Levels of IL-6 and soluble IL-6 receptor are increased in HIV patients with a history of immune restoration disease after HAART. HIV Med (2002) 1.26
Characterization of the respiratory NADH dehydrogenase of Escherichia coli and reconstitution of NADH oxidase in ndh mutant membrane vesicles. Biochemistry (1981) 1.25
Thyroxine transport from blood to brain via transthyretin synthesis in choroid plexus. Am J Physiol (1990) 1.23
Hepatic steatosis and lactic acidosis associated with stavudine treatment in an HIV patient: a case report. AIDS (1997) 1.22
Endothelial function in HIV-infected patients receiving protease inhibitor therapy: does immune competence affect cardiovascular risk? QJM (2003) 1.16
Acutely dysregulated, chronically disabled by the enemy within: T-cell responses to HIV-1 infection. Immunol Cell Biol (2006) 1.14
HIV infection of monocyte-derived macrophages in vitro reduces phagocytosis of Candida albicans. J Leukoc Biol (1994) 1.11
Active multilayered capsules for in vivo bone formation. Proc Natl Acad Sci U S A (2010) 1.11
Immune dysfunction and immune restoration disease in HIV patients given highly active antiretroviral therapy. J Clin Virol (2001) 1.11
Exposure to blood borne infections in health care workers. Med J Aust (1992) 1.10
Genetic regulation of autoimmune disease: BALB/c background TGF-beta 1-deficient mice develop necroinflammatory IFN-gamma-dependent hepatitis. J Immunol (2001) 1.10
Genetic identification and purification of the respiratory NADH dehydrogenase of Escherichia coli. Biochemistry (1981) 1.09
Functional implications of the human T-lymphotropic virus type 1 transmembrane glycoprotein helical hairpin structure. J Virol (2000) 1.08
The IgG4 subclass is associated with a low affinity antibody response to tetanus toxoid in man. Immunology (1985) 1.05
Plasma bioavailable interleukin-6 is elevated in human immunodeficiency virus-infected patients who experience herpesvirus-associated immune restoration disease after start of highly active antiretroviral therapy. J Infect Dis (2001) 1.05
Rapid restoration of CD4 T cell subsets in subjects receiving antiretroviral therapy during primary HIV-1 infection. AIDS (2000) 1.03
Genetic vaccination strategies for enhanced cellular, humoral and mucosal immunity. Immunol Rev (1999) 1.02
Enhanced cellular immunity in macaques following a novel peptide immunotherapy. J Virol (2005) 1.02
Protein losing enteropathy due to systemic lupus erythematosus. Gut (1984) 1.02
Amputations: no longer the end of the road. J R Coll Surg Edinb (2001) 1.01
Major histocompatibility complex genes influence the outcome of HIV infection. Ancestral haplotypes with C4 null alleles explain diverse HLA associations. Hum Immunol (1990) 0.99
Novel sensitive real-time PCR for quantification of bacterial 16S rRNA genes in plasma of HIV-infected patients as a marker for microbial translocation. J Clin Microbiol (2011) 0.98
Antibody-dependent cellular cytotoxicity of human vascular endothelium in systemic lupus erythematosus. J Clin Lab Immunol (1985) 0.96
Immune complexes in systemic sclerosis; detection by C1q binding, K-cell inhibition and Raji cell radioimmunoassays. J Clin Lab Immunol (1983) 0.95
A minimally replicative HIV-2 live-virus vaccine protects M. nemestrina from disease after HIV-2(287) challenge. Virology (1998) 0.95
Epidemiology of late presentation of HIV infection in Western Australia. Med J Aust (1992) 0.95
Colony-stimulating factor 1-induced STAT1 and STAT3 activation is accompanied by phosphorylation of Tyk2 in macrophages and Tyk2 and JAK1 in fibroblasts. Blood (1995) 0.95
Granulocyte-macrophage colony-stimulating factor inhibits HIV-1 replication in monocyte-derived macrophages. AIDS (2000) 0.93
Cytomegalovirus (CMV)-specific CD8+ T cells in individuals with HIV infection: correlation with protection from CMV disease. J Antimicrob Chemother (2006) 0.93
An evaluation of serum soluble CD30 levels and serum CD26 (DPPIV) enzyme activity as markers of type 2 and type 1 cytokines in HIV patients receiving highly active antiretroviral therapy. Clin Exp Immunol (2001) 0.93
Successful pregnancy following steroid therapy and plasma exchange in a woman with anti-Ro (SS-A) antibodies. Case report. Br J Obstet Gynaecol (1987) 0.92
Which surgeons in a district general hospital should treat patients with carcinoma of the rectum? J R Coll Surg Edinb (1995) 0.92
Immunoglobulin G subclass distribution of autoantibodies in systemic sclerosis, primary biliary cirrhosis, and overlap syndromes. Ann Rheum Dis (1987) 0.91
MHC haplotypes affect the expression of opportunistic infections in HIV patients. Hum Immunol (2001) 0.91
Targeting improves the efficacy of a DNA vaccine against Corynebacterium pseudotuberculosis in sheep. Infect Immun (1999) 0.90
Combined analysis of two-year follow-up from two open-label randomized trials comparing efficacy of three nucleoside reverse transcriptase inhibitor backbones for previously untreated HIV-1 infection: OzCombo 1 and 2. HIV Clin Trials (2003) 0.90
Synthesis of specific fatty acids contributes to VLDL-triacylglycerol composition in humans with and without type 2 diabetes. Diabetologia (2009) 0.89
The frequency of high-grade intraepithelial neoplasia in anal/perianal warts is higher than previously recognized. Int J STD AIDS (2007) 0.89
Transthyretin (prealbumin) gene expression in choroid plexus is strongly conserved during evolution of vertebrates. Comp Biochem Physiol B (1991) 0.89
Can HIV infection be prevented with a vaccine? Drugs R D (1999) 0.89
Developmental patterns of gene expression of secreted proteins in brain and choroid plexus. Dev Biol (1989) 0.89
The value of arteriography of the hand in the Raynaud's syndrome. J Cardiovasc Surg (Torino) (1976) 0.89
GM phenotypes influence the concentrations of the four subclasses of immunoglobulin G in normal human serum. Hum Immunol (1996) 0.88
Restoration of CD4 T-cell responses to cytomegalovirus is short-lived in severely immunodeficient HIV-infected patients responding to highly active antiretroviral therapy. HIV Med (2004) 0.88
Relative significance of different pathways of immune reconstitution in HIV type 1 infection as estimated by mathematical modeling. AIDS Res Hum Retroviruses (2001) 0.87
Percentage of CD3+CD4-CD8-gammadeltaTCR- T cells is increased HIV disease. AIDS Res Hum Retroviruses (2001) 0.87
Intermediates in the ribulose-1,5-bisphosphate carboxylase reaction. J Biol Chem (1984) 0.87
Anal intraepithelial neoplasia and squamous cell carcinoma in HIV-infected adults. HIV Med (2013) 0.87
Exacerbation of the inflammatory response to Mycobacterium tuberculosis after antiretroviral therapy. Med J Aust (1998) 0.87
Declining incidence and later occurrence of Kaposi's sarcoma among persons with AIDS in Australia: the Australian AIDS cohort. AIDS (1996) 0.86
Cloning of the gene for the respiratory D-lactate dehydrogenase of Escherichia coli. Biochemistry (1982) 0.86
Penetration of ceforanide and cefamandole into the right atrial appendage, pericardial fluid, sternum, and intercostal muscle of patients undergoing open heart surgery. Antimicrob Agents Chemother (1982) 0.86
Partition kinetics of ribulose-1,5-bisphosphate carboxylase from Rhodospirillum rubrum. J Biol Chem (1985) 0.85
Effects of IL-2 therapy in asymptomatic HIV-infected individuals on proliferative responses to mitogens, recall antigens and HIV-related antigens. Clin Exp Immunol (1998) 0.85
Identification of brain isoforms of the rat calcitonin receptor. Mol Endocrinol (1993) 0.84
Assessment of immune function by lymphoproliferation underestimates lymphocyte functional capacity in HIV patients treated with highly active antiretroviral therapy. AIDS Res Hum Retroviruses (2000) 0.84
MHC genes and HIV infection. Lancet (1990) 0.84
Association of IgA deficiency with HLA A28 and B14. Tissue Antigens (1983) 0.84
Quantifying complement-mediated phagocytosis by human monocyte-derived macrophages. Immunol Cell Biol (2001) 0.83
Enolpyruvate: chemical determination as a pyruvate kinase intermediate. Biochemistry (1991) 0.83
Thoracoscopy in children: anaesthesiological implications and case reports. Minerva Anestesiol (2006) 0.83
Evolutionary conservation of the membrane fusion machine. IUBMB Life (1999) 0.83
A calibration material for IgG subclass assay. J Clin Lab Immunol (1984) 0.83
Isolation, characterization, cDNA cloning and gene expression of an avian transthyretin. Implications for the evolution of structure and function of transthyretin in vertebrates. Eur J Biochem (1991) 0.82
Association between phosphatidylinositol-3 kinase, Cbl and other tyrosine phosphorylated proteins in colony-stimulating factor-1-stimulated macrophages. Biochem J (1996) 0.82
Influence of IFNgamma co-expression on the safety and antiviral efficacy of recombinant fowlpox virus HIV therapeutic vaccines following interruption of antiretroviral therapy. Hum Vaccin (2007) 0.82
Mycobacterium avium infection and immune restoration disease after highly active antiretroviral therapy in a patient with HIV and normal CD4+ counts. Eur J Clin Microbiol Infect Dis (2001) 0.82
FcgammaR-mediated phagocytosis by human macrophages involves Hck, Syk, and Pyk2 and is augmented by GM-CSF. J Leukoc Biol (2001) 0.82
A model of primary HIV-1 infection. Math Biosci (1998) 0.82
nef-deleted HIV-1 inhibits phagocytosis by monocyte-derived macrophages in vitro but not by peripheral blood monocytes in vivo. AIDS (2001) 0.82
Detection of subclinical Mycobacterium avium intracellulare complex infection in immunodeficient HIV-infected patients treated with zidovudine. AIDS (1994) 0.81
Amikacin and gentamicin accumulation pharmacokinetics and nephrotoxicity in critically ill patients. Antimicrob Agents Chemother (1981) 0.81
Separation and characterization of the activated pool of colony-stimulating factor 1 receptor forming distinct multimeric complexes with signalling molecules in macrophages. Mol Cell Biol (1999) 0.81